ICON Access, Commercialisation & Communications is an award-winning team of over 300 market access, pricing, reimbursement, and creative and digital experts who provide life sciences clients with guidance and solutions to support global brand success.
We know how payers, providers, and patients think—and what they need to see your product’s value. We have deep reach into clinical, reimbursement, and patient advocacy decision-makers through an established global advisory board of over 8,000 HTA, payer, population health, and hospital decision-makers in core markets. We work closely with 50+ leading patient advocacy groups, including EURODIS and NORD. We have extensive reach into 160,000 U.S. payer and health system decision-makers through our U.S. market access publications, P&T, and Managed Care.
With ICON as your partner you have unparalleled ability to accelerate, demonstrate, and communicate the value of your product to drive payer acceptance and increase patient access.
ICON plc, Access, Commercialisation & Communications
Year Founded: 1990
Number of Employees: 13,920
New Business Contact:
VP, Access, Commercialisation & Communications
“ICON approaches adherence holistically and as a cornerstone to commercial success. We drive patient compliance by supporting unencumbered access to therapy and providing patient consumers with information on treatment, drug administration, adverse event management and access to patient support services, such as clinical care coaching.”